CDK/HDAC-IN-3 is an orally active dual inhibitor of HDACs and CDKs, offering potent and selective inhibition of CDK9, CDK12, CDK13, HDAC1, HDAC2, and HDAC3, with IC50 values of 98.32 nM, 98.85 nM, 100 nM, 62.12 nM, 93.28 nM, and 82.87 nM, respectively, and is applicable in the treatment of acute myeloid leukemia (AML) [1].
Molecular Weight:
509.34
CAS Number:
[2944087-54-9]
Formula:
C24H18Cl2N6O3
Target:
CDK|||HDAC
T78906
* VAT and and shipping costs not included. Errors and price changes excepted
